Cherney DZI, Belmar N, Bjornstad P, Chacko MM, et al. Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease. Nephrol Dial Transplant 2025 Jul 3:gfaf114. doi: 10.1093.
PMID: 40608494